32774248|t|Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer.
32774248|a|Melanoma metastasis from an unknown primary cancer has an incidence of 3.2% among melanoma patients. Furthermore, paraneoplastic neurological syndromes (PNS) are rare, occurring in 1-3% of patients with malignancies. Paraneoplastic cerebellar degeneration (PCD) is one of the classic PNS and is characterized by acute or subacute onset of ataxia and/or presence of onconeural antibodies. A 61-year-old male with ataxia, vertigo, and headache later developed dysarthria, multidirectional nystagmus, hyperactive delirium, auditory hallucinations, psychomotor agitation, and myoclonus. Toxicological, metabolic, infectious, and autoimmune etiologies were assessed and reported negative. An osteolytic lesion was observed in the right iliac crest via computed tomography (CT). A positron emission tomography-CT reported increased fluorodeoxyglucose uptake of a right iliac and right inguinal ganglion. After biopsy of the right inguinal ganglion, a BRAF mutation-positive melanoma metastasis from an occult primary cancer was diagnosed. Dermatologic, ophthalmologic, and endoscopic gastrointestinal assessment did not reveal a primary malignant melanoma. The patient's movement disorders and neuropsychiatric symptoms improved with quetiapine, prednisone, azathioprine, and cyclophosphamide. Oncological management was conducted with MAPK pathway inhibitors (i.e., dabrafenib and trametinib). Movement disorders associated with neuropsychiatric symptoms are complex to diagnose. PNS are rare and often associated with antibodies against neural antigens expressed by the tumor. The case presented above describes a patient with a BRAF-positive malignant melanoma metastasis from an occult primary associated with PCD - to the best of our knowledge, the first reported in the literature.
32774248	0	38	Paraneoplastic Cerebellar Degeneration	Disease	MESH:D020362
32774248	52	56	BRAF	Gene	673
32774248	64	83	Melanoma Metastasis	Disease	MESH:D009362
32774248	99	113	Primary Cancer	Disease	MESH:D009369
32774248	115	134	Melanoma metastasis	Disease	MESH:D009362
32774248	151	165	primary cancer	Disease	MESH:D009369
32774248	197	205	melanoma	Disease	MESH:D008545
32774248	206	214	patients	Species	9606
32774248	229	266	paraneoplastic neurological syndromes	Disease	MESH:D020361
32774248	268	271	PNS	Disease	MESH:D020361
32774248	304	312	patients	Species	9606
32774248	318	330	malignancies	Disease	MESH:D009369
32774248	332	370	Paraneoplastic cerebellar degeneration	Disease	MESH:D020362
32774248	372	375	PCD	Disease	MESH:D020362
32774248	399	402	PNS	Disease	MESH:D020361
32774248	454	460	ataxia	Disease	MESH:D001259
32774248	527	533	ataxia	Disease	MESH:D001259
32774248	535	542	vertigo	Disease	MESH:D014717
32774248	548	556	headache	Disease	MESH:D006261
32774248	573	583	dysarthria	Disease	MESH:D004401
32774248	602	611	nystagmus	Disease	MESH:D009759
32774248	613	633	hyperactive delirium	Disease	MESH:D003693
32774248	635	658	auditory hallucinations	Disease	MESH:D006212
32774248	660	681	psychomotor agitation	Disease	MESH:D011595
32774248	687	696	myoclonus	Disease	MESH:D009207
32774248	802	819	osteolytic lesion	Disease	MESH:D030981
32774248	941	959	fluorodeoxyglucose	Chemical	MESH:D019788
32774248	1060	1064	BRAF	Gene	673
32774248	1083	1102	melanoma metastasis	Disease	MESH:D009362
32774248	1118	1132	primary cancer	Disease	MESH:D009369
32774248	1246	1264	malignant melanoma	Disease	MESH:D008545
32774248	1270	1277	patient	Species	9606
32774248	1280	1298	movement disorders	Disease	MESH:D009069
32774248	1303	1328	neuropsychiatric symptoms	Disease	MESH:D001523
32774248	1343	1353	quetiapine	Chemical	MESH:D000069348
32774248	1355	1365	prednisone	Chemical	MESH:D011241
32774248	1367	1379	azathioprine	Chemical	MESH:D001379
32774248	1385	1401	cyclophosphamide	Chemical	MESH:D003520
32774248	1476	1486	dabrafenib	Chemical	MESH:C561627
32774248	1491	1501	trametinib	Chemical	MESH:C560077
32774248	1504	1522	Movement disorders	Disease	MESH:D009069
32774248	1539	1564	neuropsychiatric symptoms	Disease	MESH:D001523
32774248	1590	1593	PNS	Disease	MESH:D020361
32774248	1681	1686	tumor	Disease	MESH:D009369
32774248	1725	1732	patient	Species	9606
32774248	1740	1744	BRAF	Gene	673
32774248	1764	1783	melanoma metastasis	Disease	MESH:D009362
32774248	1823	1826	PCD	Disease	MESH:D020362
32774248	Negative_Correlation	MESH:D000069348	MESH:D009069
32774248	Negative_Correlation	MESH:D001379	MESH:D014717
32774248	Negative_Correlation	MESH:D011241	MESH:D009759
32774248	Negative_Correlation	MESH:D011241	MESH:D004401
32774248	Negative_Correlation	MESH:C561627	MESH:D009362
32774248	Negative_Correlation	MESH:D000069348	MESH:D014717
32774248	Negative_Correlation	MESH:D000069348	MESH:D001523
32774248	Negative_Correlation	MESH:D011241	MESH:D001259
32774248	Negative_Correlation	MESH:D003520	MESH:D014717
32774248	Association	MESH:D020362	673
32774248	Negative_Correlation	MESH:D003520	MESH:D009069
32774248	Negative_Correlation	MESH:D001379	MESH:D001523
32774248	Negative_Correlation	MESH:D003520	MESH:D001523
32774248	Negative_Correlation	MESH:D011241	MESH:D014717
32774248	Negative_Correlation	MESH:C561627	MESH:D001523
32774248	Negative_Correlation	MESH:D011241	MESH:D001523
32774248	Negative_Correlation	MESH:C560077	MESH:D001523
32774248	Association	MESH:D009362	673
32774248	Negative_Correlation	MESH:C561627	MESH:D009069
32774248	Negative_Correlation	MESH:D011241	MESH:D009069
32774248	Negative_Correlation	MESH:D011241	MESH:D006261
32774248	Negative_Correlation	MESH:D001379	MESH:D009069

